These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 2422994

  • 1. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
    Bonadonna G, Valagussa P, Santoro A.
    Ann Intern Med; 1986 Jun; 104(6):739-46. PubMed ID: 2422994
    [Abstract] [Full Text] [Related]

  • 2. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B.
    J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
    [Abstract] [Full Text] [Related]

  • 3. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G, Santoro A, Bonfante V, Valagussa P.
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [Abstract] [Full Text] [Related]

  • 4. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP.
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H, Stuve W, Behrendt H.
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [Abstract] [Full Text] [Related]

  • 7. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
    Viviani S, Bonadonna G, Santoro A, Bonfante V, Zanini M, Devizzi L, Soncini F, Valagussa P.
    J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
    Harker WG, Kushlan P, Rosenberg SA.
    Ann Intern Med; 1984 Oct; 101(4):440-6. PubMed ID: 6206757
    [Abstract] [Full Text] [Related]

  • 9. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Carella AM, Congiu AM, Gaozza E, Mazza P, Ricci P, Visani G, Meloni G, Cimino G, Mangoni L, Coser P.
    J Clin Oncol; 1988 Sep; 6(9):1411-6. PubMed ID: 2458439
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
    Chisesi T, Bellei M, Luminari S, Montanini A, Marcheselli L, Levis A, Gobbi P, Vitolo U, Stelitano C, Pavone V, Merli F, Liberati M, Baldini L, Bordonaro R, Pesce EA, Federico M.
    J Clin Oncol; 2011 Nov 10; 29(32):4227-33. PubMed ID: 21990405
    [Abstract] [Full Text] [Related]

  • 12. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT.
    J Clin Oncol; 1997 Nov 10; 15(11):3338-46. PubMed ID: 9363863
    [Abstract] [Full Text] [Related]

  • 13. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
    Glick JH, Young ML, Harrington D, Schilsky RL, Beck T, Neiman R, Fisher RI, Peterson BA, Oken MM.
    J Clin Oncol; 1998 Jan 10; 16(1):19-26. PubMed ID: 9440718
    [Abstract] [Full Text] [Related]

  • 14. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Oberlin O, Leverger G, Pacquement H, Raquin MA, Chompret A, Habrand JL, Terrier-Lacombe MJ, Bey P, Bertrand Y, Rubie H.
    J Clin Oncol; 1992 Oct 10; 10(10):1602-8. PubMed ID: 1383434
    [Abstract] [Full Text] [Related]

  • 15. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K, Utsumi M, Shimoyama M.
    Gan To Kagaku Ryoho; 1998 Dec 10; 25(14):2202-9. PubMed ID: 9881076
    [Abstract] [Full Text] [Related]

  • 16. Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
    Viviani S, Bonadonna G, Santoro A, Zanini M, Zucali R, Negretti E, Valagussa P.
    Ann Oncol; 1991 Feb 10; 2 Suppl 2():55-62. PubMed ID: 1710921
    [Abstract] [Full Text] [Related]

  • 17. Alternating drug combinations in the treatment of advanced Hodgkin's disease.
    Santoro A, Bonadonna G, Bonfante V, Valagussa P.
    N Engl J Med; 1982 Apr 01; 306(13):770-5. PubMed ID: 6174865
    [Abstract] [Full Text] [Related]

  • 18. A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
    Machiels JP, Ferrant A, Martiat P, Doyen C, Bosly A, Michaux JL.
    Acta Clin Belg; 1992 Apr 01; 47(4):244-50. PubMed ID: 1384256
    [Abstract] [Full Text] [Related]

  • 19. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M, Intergruppo Italiano Linfomi.
    J Clin Oncol; 2005 Dec 20; 23(36):9198-207. PubMed ID: 16172458
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.